You are here

Glaxo presses on to find the next critical antibiotic

Despite the rise of superbugs, big pharma has largely exited antibiotic research because of low payoff

Penicillin changed the world; infections that previously killed people were now treatable, paving the way for safer operations from organ transplants to hip replacements.


IN A cramped lab in rural Penn-sylvania, surrounded by technicians in obligatory white lab coats and fume hoods leaking an occasional acrid smell, Neil Pearson holds up a plastic model of a chemical compound that resembles a spidery piece of Lego.

Mr Pearson, a 54-year-old